Global Editions

23andMe thinks polygenic risk scores are ready for the masses, but experts aren’t so sure

A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale.
by Antonio Regalado

23andMe, the direct-to-consumer DNA testing company in Silicon Valley whose motto is “Everyone has a right to their genetic information,” is rolling out a potentially controversial new type of disease prediction.

Today at the SXSW festival in Austin, and via press release, 23andMe is announcing plans to a commercialize a DNA assessment it says will…


اسے اردو میں پڑھیں